ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma.

Wang, Dong; Xu, Yaping; Goldstein, Jennifer B; Ye, Ke; Hu, Xi; Xiao, Liang; Li, Lifeng; Chang, Lianpeng; Guan, Yanfang; Long, Guo; He, Qiongzhi; Yi, Xin; Zhang, Jianjun; Wang, Zhiming; Xia, Xuefeng; Zhou, LeduUNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER; University of Texas MD Anderson Cancer Center; The University of Texas M.D anderson Cancer Center; University of Texas, M.D. Anderson Cancer Center; The University of Texas M.D Anderson Cancer Center; University of Texas M. D. Anderson Cancer Center; The University of Texas M.D.Anderson Cancer Center; The University of Texas MD Anderson Cancer Center; University of Texas M.D.Anderson cancer center; The University of Texas, MD Anderson Cancer Center; University of Texas, MD Anderson Cancer Center; University of Texas,M.D.Anderson Cancer Center; The university of Texas,M.D.Anderson Cancer Center; the university of Texas MD Anderson Cancer Center; University Of Texas MD Anderson Cancer Center; University of Texas M.D.Anderson Cancer Center
Liver International2020-4-12DOI: 10.1111/liv.14463
10被引12阅读
引用收藏
分享

摘要

BACKGROUND & AIMS: Microvascular invasion (MVI) is a critical prognostic factor for operable hepatocellular carcinoma (HCC). This study aimed to explore the performance of circulating tumour DNA (ctDNA) in evaluating MVI status preoperatively. METHODS: Seventy-three HCC patients were enrolled and randomly divided into a training cohort and a validation cohort in a 2:1 ratio, and preoperative blood and surgical tissue samples were obtained. Genomic alterations were analysed using targeted deep sequencing with a 1021-gene panel. RESULTS: In training cohort, 260 somatic mutations were identified in 40 blood samples (81.6%). CtDNA mutation was verified in paired tissue sample in 39 patients (97.5%). In univariate analysis, ctDNA allele frequency (AF) and largest tumour diameter were associated with the presence of MVI, but ctDNA AF was the only independent risk factor in multivariate analysis. With the cut-off value of 0.83%, ctDNA AF determined the presence of MVI with the sensitivity of 89.7% and specificity of 80.0% in the training cohort, and the sensitivity of 78.6% and the specificity of 81.8% in the validation cohort. In preoperative evaluation, ctDNA AF, AFP level and BCLC staging were associated with recurrence-free survival in both univariate and multivariate analysis. CONCLUSIONS: CtDNA can serve as an independent risk factor of MVI for operable HCC and help determining precise treatment strategies. The integration of ctDNA in the management of operable HCC may achieve better clinical outcomes.

学科与关键词

关键词
ctDNAhepatectomyhepatocellular carcinomamicrovascular invasionsurgical management
相关
加载中…
  • Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma
    Xu, Tingfeng; Ren, Liying; Liao, Minjun; Zhao, Bigeng; Wei, Rongyu; Zhou, Zhipeng; He, Yong; Zhang, Hao; Chen, Dongbo; Chen, Hongsong*; Liao, Weijia*Journal of Hepatocellular Carcinoma, 2022, 9: 189-201.被引 8
  • Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
    Ge, Zhouhong; Helmijr, Jean C. A.; Jansen, Maurice P. H. M.; Boor, Patrick P. C.; Noordam, Lisanne; Peppelenbosch, Maikel; Kwekkeboom, Jaap; Kraan, Jaco; Sprengers, Dave*Translational Oncology, 2021, 14(7): 101073.
  • Postoperative minimal residual disease to predict the risk of hepatocellular carcinoma (HCC) recurrence using plasma-only circulating tumor DNA assay
    Pan, Mingxin; Cai, Jianpeng; Xu, Yuyan; Zhong, Kaihang; Chen, TingtingAnnual Meeting of the American-Association-for-Cancer-Research (AACR), New Orleans, LA, 2022-04-08 To 2022-04-13.
查看全部 →

发表信息

论文状态
公开发表
期刊
Liver International
发表日期
2020-04-12
DOI
10.1111/liv.14463
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
PUBMED

作者

  • W

    Wang, Dong (第一作者)

  • X

    Xu, Yaping

查看全部 16 位作者收起作者
  • G

    Goldstein, Jennifer B

    the university of texas md anderson cancer center

  • Y

    Ye, Ke

  • H

    Hu, Xi

  • X

    Xiao, Liang

  • L

    Li, Lifeng

  • C

    Chang, Lianpeng

  • G

    Guan, Yanfang

  • L

    Long, Guo

  • H

    He, Qiongzhi

  • Y

    Yi, Xin

  • Z

    Zhang, Jianjun

    university of texas md anderson cancer center

  • W

    Wang, Zhiming

  • X

    Xia, Xuefeng

  • Z

    Zhou, Ledu

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417